Loading data
NVNONasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 9.98 m USD | 12.25 m USD | 13.58 m USD | 9.91 m USD | 5.73 m USD |
| Selling, general and administrative expense | 10.92 m USD | 11.58 m USD | 11.66 m USD | 15.02 m USD | 11.17 m USD |
| Operating profit | -20.9 m USD | -23.83 m USD | -25.24 m USD | -24.93 m USD | -16.89 m USD |
| Profit before tax | -19.47 m USD | -21.82 m USD | — | — | — |
| Net income (reported basis) | -19.47 m USD | -21.82 m USD | -23.52 m USD | -24.67 m USD | -16.53 m USD |
| Basic earnings per share | -33.06 USD/share | -44.53 USD/share | -1.91 USD/share | -2.2 USD/share | -1.9 USD/share |
| Diluted earnings per share | -33.06 USD/share | -44.53 USD/share | -1.91 USD/share | -2.2 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.